Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK/PD of HSK3486 in Hepatic Impairment
NCT04145596Phase 1Completed
- Sponsor
- Sichuan Haisco Pharmaceutical Co., Ltd.
- Start
- Nov 2019
- Primary completion
- Apr 2020
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
Phase 1, open-label trial of ciprofol in Anesthesia and Procedural sedation (PS) (3 arms), sponsored by Sichuan Haisco Pharmaceutical Co., Ltd. Primary endpoints: Peak Concentration at 24 hours and Area Under the Concentration-Time Curve at 24 hours. Started Nov 2019; status: completed.
02
Drugs
ciprofol
03
Conditions
AnesthesiaProcedural sedation (PS)
Beyond the preview
Go deeper on NCT04145596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04145596.